Becton, Dickinson and Company

BDX

HealthcareMedical - Instruments & SuppliesNYSE

$158.80

Market Cap: $57.53B

Becton, Dickinson and Company (BDX) Analyst Estimates

▲ Wall Street analysts forecast BDX to rise 22% over the next 12 months.

Avg Price Target

$193.80

+22.0% upside

According to Wall Street analysts, the average 12-month price target for Becton, Dickinson and Company (BDX) is $193.80, implying +22.0% upside from the current price of $158.80.